Tag: Diabetes: Type II
Breaking Up Prolonged Sitting Benefits Postmenopausal Women
Reductions in postprandial glucose, insulin, NEFA responses for overweight/obese women
Testosterone Treatment Tied to Improved Insulin Sensitivity
Increased insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism
Lixisenatide Doesn’t Affect Cardiovascular Risk in T2DM
Findings among patients with type 2 diabetes and recent acute coronary syndrome
Basal Insulin Peglispro Beats Glargine for Glycemic Control
In T2DM, also tied to increased triglycerides, aminotransferases, and liver fat content
Animal-Source, Low-Carb Diet Ups T2DM Risk With Past GDM
Increased risk of T2DM for overall low-carbohydrate diet scores and animal LCD scores
Breastfeeding May Reduce Risk of T2DM for Women With GDM
Findings for women with previously diagnosed gestational diabetes
Maintenance of LDL, HbA1c Goals With Pharmacist-Led Program
LDL-C, HbA1c goals maintained after veterans with T2DM discharged from pharmacist-managed clinic
Group Medicine Appointments Effective for Glycemic Control
Greater proportion of patients with T2DM reach target HbA1c levels; faster rate of HbA1c decline
Sildenafil Improves Insulin Sensitivity in Prediabetes
Decrease in plasminogen activator inhibitor-1 without affecting tissue-plasminogen activator
GLP-1 Receptor Agonists Can Manage Postprandial Glucose
Effective for postprandial glucose management in patients with type 2 diabetes on basal insulin
